Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 15,275 | 20,336 | 18,519 | 18,702 | 12,785 |
| Gross Profit | 15,275 | 20,336 | 18,519 | 18,702 | 12,785 |
| Operating Expenses | 49,269 | 48,973 | 43,249 | 31,871 | 25,567 |
| Operating Income | -33,994 | -28,637 | -24,730 | -13,169 | -12,782 |
| Interest Expense | 53 | 70 | 28 | 24 | 28 |
| Other Income | 147 | 125 | 98 | 118 | 124 |
| Pre-tax Income | -33,900 | -28,582 | -24,660 | -13,075 | -12,686 |
| Net Income Continuous | -33,900 | -28,582 | -24,660 | -13,075 | -12,686 |
| Net Income | $-33,900 | $-28,582 | $-24,660 | $-13,075 | $-12,686 |
| EPS Basic Total Ops | -0.69 | -0.56 | -0.55 | -0.29 | 14.45 |
| EPS Basic Continuous Ops | -0.69 | -0.56 | -0.55 | -0.29 | 10.34 |
| EPS Diluted Total Ops | -0.69 | -0.56 | -0.55 | -0.29 | 14.45 |
| EPS Diluted Continuous Ops | -0.69 | -0.56 | -0.55 | -0.29 | 10.34 |
| EBITDA(a) | $-31,669 | $-26,306 | $-22,946 | $-11,405 | $-10,714 |